Health economics in haemophilia: a review from the clinician's perspective

Health economic evaluations provide valuable information for healthcare providers, facilitating the treatment decision‐making process in a climate where demand for healthcare exceeds the supply. Although an uncommon disease, haemophilia is a life‐long condition that places a considerable burden on p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2010-05, Vol.16 (s3), p.29-34
1. Verfasser:	ESCOBAR, M. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost-Benefit Analysis cost-effectiveness cost-utility Factor VIIa - economics Factor VIIa - therapeutic use haemophilia Health Care Costs health economics Hemophilia A - drug therapy Hemophilia A - economics Hemophilia B - drug therapy Hemophilia B - economics Hemorrhage - economics Hemorrhage - prevention & control Humans pd-APCC Quality of Life Quality-Adjusted Life Years Recombinant Proteins - economics Recombinant Proteins - therapeutic use rFVIIa
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!